This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- King of Prussia, PA (US) (2019 - 2021)
- Collegeville, PA (US) (2021 - 2022)
Company Filing History:
Years Active: 2019-2022
Title: Deepak Bandyopadhyay: Innovator in Kinase Inhibitors
Introduction
Deepak Bandyopadhyay is a prominent inventor based in King of Prussia, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 6 patents to his name, Bandyopadhyay continues to push the boundaries of innovation in pharmaceutical research.
Latest Patents
One of his latest patents includes the development of heterocyclic amides as kinase inhibitors. This patent discloses compounds that have the potential to play a crucial role in treating various diseases by targeting specific kinases involved in cellular processes.
Career Highlights
Bandyopadhyay is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in drug development and patent strategy. His work has been instrumental in advancing the company's research initiatives and enhancing its intellectual property portfolio.
Collaborations
Throughout his career, Bandyopadhyay has collaborated with notable colleagues, including Jae U Jeong and Patrick M Eidam. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Deepak Bandyopadhyay is a key figure in the field of kinase inhibitors, with a strong patent portfolio and a commitment to advancing pharmaceutical research. His contributions continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile